|Bid||83.81 x 800|
|Ask||86.39 x 1800|
|Day's Range||85.21 - 86.38|
|52 Week Range||73.12 - 88.91|
|Beta (5Y Monthly)||0.64|
|PE Ratio (TTM)||36.03|
|Earnings Date||Feb. 02, 2022 - Feb. 07, 2022|
|Forward Dividend & Yield||1.12 (1.30%)|
|Ex-Dividend Date||Dec. 02, 2021|
|1y Target Est||95.86|
Investors are optimistic about Chemed (CHE), given impressive performance of the Roto-Rooter arm and solid growth in VITAS admissions.
Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and increasing urine output in ADHF patients.
Here is how ATI Physical Therapy, Inc. (ATIP) and Baxter International (BAX) have performed compared to their sector so far this year.